Back
Cartesian Therapeutics Vs. Johnson & Johnson Industry Stock Comparison
Sell
37
RNAC
Cartesian Therapeutics
Last Price:
16.33
Seasonality Move:
-14.99%
Sell
50
JNJ
Johnson & Johnson
Last Price:
166.69
Seasonality Move:
3.62%
Sell
37
Cartesian Therapeutics (RNAC)
is a Sell
Is Cartesian Therapeutics a Buy, Sell or Hold?
- The current Cartesian Therapeutics [RNAC] share price is $16.75. The Score for RNAC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- RNAC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Johnson & Johnson (JNJ)
is a Sell
Is Johnson & Johnson a Buy, Sell or Hold?
- The current Johnson & Johnson [JNJ] share price is $165.52. The Score for JNJ is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- JNJ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RNAC Stock Price Chart
What is Cartesian Therapeutics's stock price today?
-
The Cartesian Therapeutics share price today is $16.75
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNAC is experiencing buying pressure, which is a positive indicator for future bullish movement.
JNJ Stock Price Chart
What is Johnson & Johnson's stock price today?
-
The Johnson & Johnson share price today is $165.52
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JNJ is experiencing buying pressure, which is a positive indicator for future bullish movement.
RNAC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 60.37 | Buy |
Chaikin Money Flow: | 26939 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.19 - 15.15) | Buy |
Bollinger Bands (100): | (14.16 - 27.02) | Sell |
JNJ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.91 | Buy |
Relative Strength Index (14 RSI): | 58.08 | Buy |
Chaikin Money Flow: | 2784188 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (160.23 - 166.01) | Buy |
Bollinger Bands (100): | (146.47 - 160.75) | Buy |
RNAC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.63 | Buy |
20-day SMA: | 14.35 | Buy |
50-day SMA: | 15.28 | Buy |
200-day SMA: | 20.86 | Sell |
8-day EMA: | 15.15 | Buy |
20-day EMA: | 14.69 | Buy |
50-day EMA: | 16.18 | Buy |
200-day EMA: | 21.88 | Sell |
JNJ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 165.71 | Sell |
20-day SMA: | 164.08 | Buy |
50-day SMA: | 159.16 | Buy |
200-day SMA: | 155.28 | Buy |
8-day EMA: | 165.38 | Buy |
20-day EMA: | 164 | Buy |
50-day EMA: | 160.02 | Buy |
200-day EMA: | 156.27 | Buy |
Cartesian Therapeutics Earnings Growth & RNAC Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $2.16 per share.
Johnson & Johnson Earnings Growth & JNJ Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, an increase next quarter of $0.57 per share, an increase this year of $0.08 per share, and an increase next year of $0.71 per share.
Cartesian Therapeutics Technical Analysis
Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Johnson & Johnson Technical Analysis
Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |